Method of reducing the occurrence of macular and neuroretinal degenerations by alleviating age related retinal stresses as a contributing factor in a mammalian eye

• US 9,974,645 B2
• Filed: 12/18/2014
• Issued: 05/22/2018
• Est. Priority Date: 08/07/2012
• Status: Active Grant

• Current Assignee: Peter Renke
• Original Assignee: Regeneye, LLC
• Inventors: Renke, Peter
• Primary Examiner(s): Klein, Benjamin
• Application Number:
  US14/575,871
• Publication Number:
  US 20150164635A1
• Time in Patent Office: 1,251 Days
• CPC Class Codes: A61F 2/14 Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
• CPC Class Codes: A61F 2/82 Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95; for closing wounds, or holding wounds closed A61B17/04 - A61B17/115; dilators A61M29/00
• CPC Class Codes: A61F 9/007 Methods or devices for eye surgery
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

A method of reducing the risk of macular degeneration is provided. The method includes inserting an intraocular collar stent into a portion of a mammalian eye, such that the stent is in contact with soft tissue of the anterior chamber. When inserted in the eye, the stent applies pressure to a surface centered on a transition zone, between an anterior limit of a trabecular meshwork and a posterior limit of a corneal endothelium of the eye, to a surface of the peripheral iris of the eye, and in circumferentially expanding direction to the irideocorneal angle. The pressure is applied continually. The method also includes creating an environment of a reduced negative pressure state within the retina as a result of the application of the pressure; and, while the reduced negative pressure state is present, permitting drusen precursors formed by extracellular material to flow through the eye for removal by vasculature of the eye.

Claims

1. A method of mitigating the occurrence of macular degeneration in a mammalian eye, the method comprising;

inserting an intraocular collar stent into a portion of the mammalian eye such that the collar stent is in contact with soft tissue of an anterior chamber of the eye;

applying pressure in an anterior direction to a surface centered on a transition zone between an anterior limit of a trabecular meshwork and a posterior limit of a corneal endothelium of the eye with an anterior portion of the stent;

applying pressure in a posterior direction to a surface of a peripheral iris of the eye with a posterior portion of the stent, wherein the pressure is applied continually;

applying pressure in a circumferentially expanding direction to an iridocorneal angle of the eye, wherein the pressure is applied continually;

creating a reduced negative pressure state within retinal tissues of the eye as a result of the application of pressure; and

while the reduced negative pressure state is present, permitting enhanced removal of extracellular material to flow through vasculature of the eye.

2. The method of claim 1, wherein inserting the stent comprises:

forming an incision in a cornea of the eye for accessing the anterior chamber;

inserting a portion of an injector into the anterior chamber through the incision; and

expelling the stent from the injector to the anterior chamber for placement.

3. The method of claim 1, wherein the intraocular collar stent comprises a body, the body comprising the anterior portion configured to contact the surface of the transition zone and the posterior portion configured to contact the peripheral iris of the eye.

4. The method of claim 3, wherein the body further comprises a joint connecting the anterior portion and the posterior portion of the body.

5. The method of claim 4, wherein the joint comprises an articulating joint configured to adjust the position of the anterior and posterior portions of the body relative to interior structures of the eye.

6. The method of claim 5, wherein the articulating joint defines an interior angle and an exterior angle, the exterior angle being commensurate with and configured to fit within the iridocorneal angle of the eye.

7. The method of claim 3, wherein the body comprises one or more biocompatible materials selected from the group consisting of:

polymethylmethacrylate (PMMA);

silicone or acrylic block polymers materials having PMMA components;

hydrophobic acrylics;

hydrophilic acrylics;

acrylic Poly(styrene-block-isobutylene-block-styrene) SIBS;

Silicon Elastomer (Biosil); and

Heparin Surface Modified Acrylics.

8. The method of claim 3, wherein the anterior portion of the body comprises a plurality of notches or beads extending therefrom configured to create non-continuous contact with the transition zone.

9. The method of claim 3, wherein the intraocular collar stent is inserted in the eye such that the anterior portion of the body extends around the iridocorneal angle of the eye and crosses an anterior chamber exposure of a ciliary body up to or beyond a scleral spur of the eye.

10. The method of claim 1, wherein applying pressure in at least one of the anterior direction and the posterior direction absorbs static stresses to a retina caused by ineffective focusing.

11. The method of claim 1, wherein applying pressure in at least one of the anterior direction and the posterior direction at least partially contributes to elimination of a negative pressure in an extracellular space of the eye.

12. The method of claim 1, wherein the pressure in the anterior direction and the pressure in the posterior direction are applied simultaneously.

13. The method of claim 1, wherein the pressure in the anterior direction and the pressure in the posterior direction are applied continually for a predetermined period of time.

14. The method of claim 1, wherein the application of pressure in at least one of the anterior direction and the posterior direction produces the reduced negative pressure state in the eye in which drusen formation is at least partially inhibited.